Abstract Library

#3516 177Lutetium-Peptide Receptor Radionuclide Therapy (PRRT) safety assessment in patients with refractory Gastro-Entero-Pancreatic Neuroendocrine Tumors (GEP NETs)

Introduction: 177Lu-PRRT became an established therapeutic modality in inoperable or metastatic NETs, demonstrating substantial survival benefits and reassuring safety profile. Dosimetry of Organs-At-Risk [OAR, kidneys, bone marrow (BM) and spleen] and malignant lesions ensures to further optimize its safety and efficacy.

Conference:

Presenting Author: van Bogaert C

Authors: van Bogaert C, Mileva M, Marin G, Levillain H, Artigas-Guix C,

Keywords: PRRT, Safety, Dosimetry, Prospective trial,

#2162 Single Cell Copy Number Variation Analysis (CNV) of Circulating Tumor Cells (CTCs) in Neuroendocrine Tumor (NET) Patients

Introduction: The identification and characterization of CTCs as part of a minimally invasive “liquid biopsy” provides an opportunity to explore NET biology, identify therapeutic targets and investigate tumour heterogeneity.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Childs A

Authors: Childs A, Vesely C, Rizzo F, Ensell L, Lowe H,

Keywords: CTCs, tumor heterogeneity, CNV,

#2080 Linked Colour Imaging Increases the Diagnostic Yield of Type 1 Gastric Carcinoid

Introduction: Type 1 Gastric carcinoid tumours (GCTs) are the most common neuroendocrine tumours of the stomach. Endoscopic diagnosis of Type 1 GCTs remains a challenge. White light endoscopy (WLE) and Narrow Band Imaging (NBI) have failed to demonstrate reliable endoscopic signs of carcinoid.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Gulati S

Authors: Gulati S, Srirajaskanthan R, Ramage J, Emmanuel A, Haji A,

Keywords: gastric carcinoid, endoscopy, surveillance, therapy,

#2077 Linked Colour Imaging Increases the Diagnostic Yield of Type 1 Gastric Carcinoids

Introduction: Type 1 Gastric carcinoid tumours (GCTs) are the most common neuroendocrine tumours of the stomach. Endoscopic diagnosis of Type 1 GCTs remains a challenge. White light endoscopy (WLE) and Narrow Band Imaging (NBI) have failed to demonstrate reliable endoscopic signs of carcinoid.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Gulati S

Authors: Gulati S, Sriraja R, Ramage J, Emmanuel A, Haji A,

Keywords: gastric carcinoid, gastric neuroendocrine tumors, endoscopy, therapy, surveillance, polypectomy, endoscopic resection,

#1607 Perioperative Carcinoid Crisis During Surgery- Who Benefits from Octreotide?

Introduction: Carcinoid crisis, as an entity is poorly defined, but can be seen in patients with small bowel NET after open bowel surgery or tumour unrelated procedures as cardiovascular instability (CI)

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Elgendy K, Johnson S, French J, White S, Charnley R,

Keywords: Octreotide, carcinoid crisis,